ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Eisai expands into Chinese generics market

TOKYO -- Japanese drugmaker Eisai will acquire a Chinese generics company in a deal worth 500 million yuan ($78.2 million), gaining a bigger foothold in the world's second-largest pharmaceutical market.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more